CN102988869B - Chinese medicinal composition for treating intestinal obstruction - Google Patents

Chinese medicinal composition for treating intestinal obstruction Download PDF

Info

Publication number
CN102988869B
CN102988869B CN201210476276.8A CN201210476276A CN102988869B CN 102988869 B CN102988869 B CN 102988869B CN 201210476276 A CN201210476276 A CN 201210476276A CN 102988869 B CN102988869 B CN 102988869B
Authority
CN
China
Prior art keywords
parts
chinese medicinal
radix
medicinal composition
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210476276.8A
Other languages
Chinese (zh)
Other versions
CN102988869A (en
Inventor
乔凤花
董艳丽
王先忠
王军红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qiao Fenghua
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210476276.8A priority Critical patent/CN102988869B/en
Publication of CN102988869A publication Critical patent/CN102988869A/en
Application granted granted Critical
Publication of CN102988869B publication Critical patent/CN102988869B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicinal composition for treating intestinal obstruction. The Chinese medicinal composition is prepared from the raw materials in parts by weight: 10-20 parts of Sichuan rhubarb, 10-20 parts of Sichuan incised notopterygium rhizome, 10-20 parts of radish seeds, 10-20 parts of peach seeds, 10-20 parts of red paeony roots, 10-30 parts of officinal magnolia barks, 10-30 parts of costustoot, 10-30 parts of mirabilite, 6-18 parts of bitter oranges, 6-18 parts of villous amomum fruits, 5-15 parts of bamboo shavings, 5-15 parts of pinellia tubers and 1-2 parts of gansui roots. The Chinese medicinal composition has the functions of purging away the heat and emptying stomach, calming the adverse-rising energy and preventing vomiting, regulating qi to eliminate swelling and disintegrating lump and removing stasis, has an obvious curative effect of treating the intestinal obstruction, and is reliable to operate, wide in component medicament sources, convenient to prepare and free of toxic and side effect.

Description

One is treated ileac Chinese medicine composition
Technical field
Medicinal preparation, the especially one of not the determining structure that the present invention relates to a kind of traditional herbal medicines are treated ileac Chinese medicine composition.
Background technology
Intestinal obstruction refers to that the intestinal that any reason causes passes through obstacle, and causes the pathological change of intestinal and whole body.Intestinal obstruction is broadly divided into mechanicalness (organic) and the large class of dynamic property (functional) two.Mechanical intestinal obstruction be due in intestinal or the outer organic disease of intestinal cause that intestinal tube stops up.The cause of disease can be that congenital developmental disorder is as intestinal atresia, intestinal stenosis, malrotation of intestine, annular pancreas, hernia incarceration etc.Posteriori reason has intussusception, the obstruction of ascarid group, volvulus, oncothlipsis, inflammation or postoperative intestine adhesion etc.Functional intestinal obstruction is to make intestinal contents normal delivery not transport because Intestinal motility is bad.Be common in the paralytic ileus that toxical paralytic ileus due to various severe pneumonias, septicemia, enteritis or hypokalemia cause.Or block etc. because of the born megacolon of the undesired elder generation causing of intestinal neurodevelopment, hypertrophic pyloric.The topmost clinical symptoms of intestinal obstruction is stomachache, vomiting, abdominal distention, stop the large symptom of exhaust defecation four.In addition, also have water, electrolyte and acid base imbalance, meet that strangulation is blocked, bowel necrosis, can occur the performances such as shock, peritonitis and gastrointestinal hemorrhage.Ileac harm is large, and the state of an illness is dangerous, has higher mortality rate.At present, except to region of obstruction, etiological diagnosis, must analyze the state of an illness clinically, the degree of blocking and character be made to diagnosis, propose treatment Countermeasures.The necessary operative treatment of mechanical intestinal obstruction; Functional intestinal intestinal obstruction is as Congenital Megacolon, and hypertrophic pyloric blocks also pogoniasis operative treatment; Infect toxical paralytic ileus or low potassium enteroparalysis except treatment protopathy, intestinal obstruction is mainly taked expectant treatment, comprises fasting, gastrointestinal decompression, and infection, venous transfusion supplements the nutrients and moisture, supplements multivitamin, also can coordinate Chinese medicine, and pin inflammation waits treatment.
The traditional Chinese medical science thinks, intestinal obstruction belongs to the categories such as the traditional Chinese medical science " stomachache " " abdominal distention ", " vomiting ", think its pathogenic factor be positive QI-insufficiency, postoperatively feel frustrated, the factor such as ascarid is blocked, domination of pathogen internal organs knot, treatment is opened it and is closed when anxious, assistant is invigorated blood circulation with ventilation.
According to theory of Chinese medical science, for ileac pathogeny, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome the deficiencies in the prior art, the invention provides a kind ofly prepare conveniently, medicine source is wide, cost is low, evident in efficacy, reliable effect, the ileac Chinese medicine composition for the treatment of that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: one is treated ileac Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: Radix Et Rhizoma Rhei 10-20 part, angelica 10-20 part, Semen Raphani 10-20 part, Semen Persicae 10-20 part, Radix Paeoniae Rubra 10-20 part, Cortex Magnoliae Officinalis 10-30 part, Radix Aucklandiae 10-30 part, Natrii Sulfas 10-30 part, Fructus Aurantii 6-18 part, Fructus Amomi 6-18 part, Caulis Bambusae In Taenia 5-15 part, Rhizoma Pinelliae 5-15 part, Radix Kansui 1-2 part.
The preferred technical solution of the present invention is: one is treated ileac Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine by following weight portion proportioning forms: 15 parts of Radix Et Rhizoma Rheis, 15 parts of angelicas, 15 parts of Semen Raphanis, 15 parts, Semen Persicae, 15 parts of Radix Paeoniae Rubra, 20 parts of Cortex Magnoliae Officinalis, 20 parts of the Radix Aucklandiae, 20 parts, Natrii Sulfas, 12 parts of Fructus Aurantiis, 12 parts of Fructus Amomis, 10 parts of Caulis Bambusae In Taenia, 10 parts of the Rhizoma Pinelliaes, 1.5 parts of Radix Kansuis.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Et Rhizoma Rhei has effect of purging heat and dredging bowels, removing pathogenic heat from blood and toxic substance from the body, eliminating blood stasis and inducing menstruation; Angelica has effect of loose exterior cold, wind-damp dispelling, sharp joint, pain relieving; Semen Raphani has effect of the de-swelling that helps digestion, lowering the adverse-rising QI to resolve phlegm; Semen Persicae has effect of blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Radix Paeoniae Rubra has effect of clearing away heat and cooling blood, eliminating stasis to stop pain; Cortex Magnoliae Officinalis has circulation of qi promoting removing food stagnancy, dampness except effect full, lowering the adverse QI to relieve asthma; The Radix Aucklandiae has effect of intestinal stasis relieving in promoting the circulation of QI to relieve pain, tune; Natrii Sulfas has purging heat to relax the bowels, moistening for dryness and softening hard mass, effect of the detumescence of relieving inflammation or internal heat; Fructus Aurantii has effect of regulating the flow of QI to ease the stomach, the stagnant relieving distension of row; Fructus Amomi has removing dampness appetizing, warming spleen and stopping diarrha, the antiabortive effect of regulating the flow of vital energy; Caulis Bambusae In Taenia has effect of clearing away heat-fire, clearing away phlegm removing heat from blood, relieving restlessness dissipating depression of QI; The Rhizoma Pinelliae has effect of drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass; Radix Kansui has effect of removing fluid-retention by purgation, dispersing swelling and dissipating binds.Drug component in the present composition is through dialectical compatibility, complements each other using, and has synergism, plays altogether effect of purging heat and dredging bowels, stopping nausea and vomiting by lowering the adverse flow of QI, the stagnant relieving distension of row, dissolving lump and resolving mass, intestinal obstruction reached to the object for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through clinical practice checking, it is evident in efficacy, reliable effect, and the property of medicine is gentle, does not occur toxic and side effects, total effective rate 96.1%, cure rate reaches 76%.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
One is treated ileac Chinese medicine composition, and its raw material of Chinese medicine by following weight proportion forms: Radix Et Rhizoma Rhei 15g, angelica 15g, Semen Raphani 15g, Semen Persicae 15g, Radix Paeoniae Rubra 15g, Cortex Magnoliae Officinalis 20g, Radix Aucklandiae 20g, Natrii Sulfas 20g, Fructus Aurantii 12g, Fructus Amomi 12g, Caulis Bambusae In Taenia 10g, Rhizoma Pinelliae 10g, Radix Kansui 1.5g.
Embodiment 2
One is treated ileac Chinese medicine composition, and its raw material of Chinese medicine by following weight proportion forms: Radix Et Rhizoma Rhei 10g, angelica 20g, Semen Raphani 10g, Semen Persicae 20g, Radix Paeoniae Rubra 10g, Cortex Magnoliae Officinalis 30g, Radix Aucklandiae 10g, Natrii Sulfas 30g, Fructus Aurantii 6g, Fructus Amomi 18g, Caulis Bambusae In Taenia 5g, Rhizoma Pinelliae 15g, Radix Kansui 1g.
Embodiment 3
One is treated ileac Chinese medicine composition, and its raw material of Chinese medicine by following weight proportion forms: Radix Et Rhizoma Rhei 20g, angelica 10g, Semen Raphani 20g, Semen Persicae 10g, Radix Paeoniae Rubra 20g, Cortex Magnoliae Officinalis 10g, Radix Aucklandiae 30g, Natrii Sulfas 10g, Fructus Aurantii 18g, Fructus Amomi 6g, Caulis Bambusae In Taenia 15g, Rhizoma Pinelliae 5g, Radix Kansui 2g.
Embodiment 4
One is treated ileac Chinese medicine composition, and its raw material of Chinese medicine by following weight proportion forms: Radix Et Rhizoma Rhei 12g, angelica 18g, Semen Raphani 12g, Semen Persicae 18g, Radix Paeoniae Rubra 12g, Cortex Magnoliae Officinalis 25g, Radix Aucklandiae 15g, Natrii Sulfas 25g, Fructus Aurantii 8g, Fructus Amomi 16g, Caulis Bambusae In Taenia 6g, Rhizoma Pinelliae 13g, Radix Kansui 1.2g.
Embodiment 5
One is treated ileac Chinese medicine composition, and its raw material of Chinese medicine by following weight proportion forms: Radix Et Rhizoma Rhei 18g, angelica 12g, Semen Raphani 18g, Semen Persicae 12g, Radix Paeoniae Rubra 18g, Cortex Magnoliae Officinalis 15g, Radix Aucklandiae 25g, Natrii Sulfas 15g, Fructus Aurantii 15g, Fructus Amomi 9g, Caulis Bambusae In Taenia 13g, Rhizoma Pinelliae 8g, Radix Kansui 1.7g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soak 15~20 minutes, then add water and do not have approximately 8 centimetres of powder, decoct.At a simmer, adopt intense fire to decoct, after boiling, use slow fire boiling 20~30 minutes; Second decocts, and after water boils, decocts 15~20 minutes.Twice decoction extracting juice that removes slag, merges.
One is treated ileac Chinese medicine composition, and clinical efficacy is summed up:
One, general data: this Chinese medicine composition is applied to clinical observation case 52 examples, wherein male 28 examples, female's 24 examples, 20~70 years old age.The shortest person of the course of disease 1 day, elder reaches 5 days, average 3 days.
Two, usage and dosage: when clinical practice, the amounts of components in compositions is taken the circumstances into consideration increase and decrease according to patient's body weight, age and symptom.Within three days, be a course for the treatment of, one day potion, the about 300ml of twice extracting juice of decocting, point early, late twice half an hour ante cibum warm taking.Period in a medicine avoids eating anything raw or cold, pungent, stimulate and rotten thing.
Three, criterion of therapeutical effect:
(1) cure: clinical cardinal symptom and sign disappear;
(2) effective: clinical cardinal symptom disappears, and minor symptom disappears substantially;
(3) invalid; Cardinal symptom is unchanged, does not also worsen.
Four, therapeutic effect: in this clinical observation case, take medicine 1-3 the course for the treatment of, cure 38 examples, effective 12 examples, invalid 2 examples.During treatment, there is not toxic and side effects.
Five, model case:
Case 1:
Liu, man, 62 years old, abdominal part distending pain, vomiting occur can not defecation, aerofluxus, is diagnosed as intestinal obstruction.Take 1 course for the treatment of of medicament prepared by Chinese medicine composition of the present invention, symptom disappears substantially, and abdominal distention obviously alleviates; Continue to strengthen 1 course for the treatment of, the healing that all disappears of all symptoms.
Case 2:
Deng, female, 24 years old, paroxysmal colic, every 3~5 minutes outbreak 1 time, outbreak intermission pain relief, during angor with bowel sound hyperaction.Take 1 course for the treatment of of medicament prepared by Chinese medicine composition of the present invention, pain relief after conscious medicine, frequency reduces.Continuous 1 course for the treatment of, the abdominal distention anesthesia of taking; Continue to strengthen and take 1 course for the treatment of, cure.

Claims (1)

1. the ileac Chinese medicine composition for the treatment of, is characterized in that: its raw material of Chinese medicine by following weight proportion forms: Radix Et Rhizoma Rhei 15g, angelica 15g, Semen Raphani 15g, Semen Persicae 15g, Radix Paeoniae Rubra 15g, Cortex Magnoliae Officinalis 20g, Radix Aucklandiae 20g, Natrii Sulfas 20g, Fructus Aurantii 12g, Fructus Amomi 12g, Caulis Bambusae In Taenia 10g, Rhizoma Pinelliae 10g, Radix Kansui 1.5g.
CN201210476276.8A 2012-11-22 2012-11-22 Chinese medicinal composition for treating intestinal obstruction Expired - Fee Related CN102988869B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210476276.8A CN102988869B (en) 2012-11-22 2012-11-22 Chinese medicinal composition for treating intestinal obstruction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210476276.8A CN102988869B (en) 2012-11-22 2012-11-22 Chinese medicinal composition for treating intestinal obstruction

Publications (2)

Publication Number Publication Date
CN102988869A CN102988869A (en) 2013-03-27
CN102988869B true CN102988869B (en) 2014-09-24

Family

ID=47918305

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210476276.8A Expired - Fee Related CN102988869B (en) 2012-11-22 2012-11-22 Chinese medicinal composition for treating intestinal obstruction

Country Status (1)

Country Link
CN (1) CN102988869B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127794A (en) * 2014-08-03 2014-11-05 李连征 Traditional Chinese medicine preparation for treating adhesive intestinal obstruction
CN104162032A (en) * 2014-08-05 2014-11-26 施怀杰 Traditional Chinese medicine for treating intestinal obstruction
CN104352992A (en) * 2014-11-26 2015-02-18 黄红妹 Traditional Chinese medicine composition for treating susceptible intestinal obstruction after colon tumor operation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152393A (en) * 2007-09-17 2008-04-02 尹克华 Traditional Chinese medicine for treating adhesive intestinal obstruction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101152393A (en) * 2007-09-17 2008-04-02 尹克华 Traditional Chinese medicine for treating adhesive intestinal obstruction

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘照伟 等.驱风通结法治疗肠梗阻初步探讨-附典型病例报告3例.《中医杂志》.1980,(第6期),第28-29页,总第428-429页.
复方大承气汤加味治疗粘连性肠梗阻25例;成志根 等;《内蒙古中医药》;20120815(第15期);第17页 *
成志根 等.复方大承气汤加味治疗粘连性肠梗阻25例.《内蒙古中医药》.2012,(第15期),第17页.
驱风通结法治疗肠梗阻初步探讨-附典型病例报告3例;刘照伟 等;《中医杂志》;19801231(第6期);第28-29页,总第428-429页 *

Also Published As

Publication number Publication date
CN102988869A (en) 2013-03-27

Similar Documents

Publication Publication Date Title
CN101066445A (en) Chinese medicine prepn for curing gastropathy radically
CN102416100B (en) Chinese medicinal composition for treating intestinal obstruction
CN103341064B (en) Chinese medicine composition for treating urine retention
CN102512630B (en) Traditional Chinese medicine composition for treating gallbladder calculus
CN102988869B (en) Chinese medicinal composition for treating intestinal obstruction
CN101658657B (en) Drug for treating chronic cholecystitis
CN102038903A (en) Traditional Chinese medicine for treating acute gastroenteritis
CN103800880A (en) Traditional Chinese medicine composition for treating spleen and kidney yang-deficiency disease
CN103006980B (en) Chinese medicinal composition for treating distention and fullness
CN102698150B (en) Oral administration traditional Chinese medicine composition for treating ulcerative colitis
CN104758726A (en) Traditional Chinese medicine composition for treating urinary tract infection
CN104587252A (en) Traditional Chinese medicine composition for treating kidney stones
CN103520652B (en) Traditional Chinese medicine composition for treating liver cancer
CN103041233A (en) Pharmaceutical composition for treating infantile diarrhea and preparation method thereof
CN103212013B (en) Chinese medicinal composition for treating epigastric pain
CN103041334B (en) Traditional Chinese medicine composition for treating abdominal distension
CN106377716A (en) Traditional Chinese medicine composition for treating dysentery
CN103550690A (en) Traditional Chinese medicine composition for treating superficial gastritis
CN103830675B (en) A kind of pharmaceutical composition for the treatment of hyperlipemia
CN106138919A (en) A kind of Chinese medicine composition treating gastric cancer
CN105749166A (en) Traditional Chinese medicine composition for treating uterine fibroid
CN106389782A (en) Traditional Chinese medicinal composition for treating acute mastitis
CN105770374A (en) Traditional Chinese medicine composition for treating uterine fibroid
CN105327024A (en) Traditional Chinese medicine preparation for treating rheumatoid arthritis
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: QIAO FENGHUA

Free format text: FORMER OWNER: DONG YANLI

Effective date: 20140825

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Qiao Fenghua

Inventor after: Dong Yanli

Inventor after: Wang Xianzhong

Inventor after: Wang Junhong

Inventor before: Dong Yanli

Inventor before: Wang Xianzhong

Inventor before: Wang Junhong

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: DONG YANLI WANG XIANZHONG WANG JUNHONG TO: QIAO FENGHUA DONG YANLI WANG XIANZHONG WANG JUNHONG

TA01 Transfer of patent application right

Effective date of registration: 20140825

Address after: 264309 Shidao, Shandong, China, the new city of Rongcheng Double Road East, No. 199

Applicant after: Qiao Fenghua

Address before: 264309 No. 16 Qinglong Road, Rongcheng Harbour Road, Shandong, Weihai

Applicant before: Dong Yanli

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140924

Termination date: 20141122

EXPY Termination of patent right or utility model